Status:
COMPLETED
Diagnostic Accuracy of Self-sampling Versus Healthcare Sampling for Coronavirus-Disease-2019 Detection.
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Emergency Medical Services, Capital Region, Denmark
Technical University of Denmark
Conditions:
COVID-19 Pandemic
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The current Coronavirus Disease 2019 (COVID-19) pandemic continues to be a worldwide health emergency. To contain the spread of disease, high demands on testing availability and capacity are observed....
Detailed Description
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting COVID-19 pandemic continue to be a worldwide health emergency resulting in national lockdown. A strategy fo...
Eligibility Criteria
Inclusion
- Age ≥ 16 years
- Having a scheduled appointment for a COVID-19 test at one of the test centers run by Testcenter Danmark in the Capital Region
Exclusion
- Non-fluent in Danish
- Impaired citizen i.e. not capable of an independent self-testing
- Neck breathers (Tracheostomy/laryngectomy patients)
- Nasopharyngeal or oropharyngeal anomalies disallowing sampling using swabs
Key Trial Info
Start Date :
February 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 6 2022
Estimated Enrollment :
3070 Patients enrolled
Trial Details
Trial ID
NCT05209178
Start Date
February 4 2022
End Date
May 6 2022
Last Update
May 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet-Copenhagen University Hospital
Copenhagen, Denmark, 2100